Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Juan G
JG
Correa
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Maria T
MT
Cibeira
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Natalia
N
Tovar
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Ignacio
I
Isola
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Fabiola
F
Pedrosa
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Tania
T
Díaz
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Ester
E
Lozano
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Laura
L
Magnano
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Laura
L
Rosiñol
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Joan
J
Bladé
Amyloidosis and Myeloma Unit, Department of Haematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Carlos
C
Fernández de Larrea
D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics* / Q000401:mortality; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D015995:Prevalence; D011379:Prognosis; D000075122:Smoldering Multiple Myeloma / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics* / Q000401:mortality; D015996:Survival Rate; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics* / Q000401:mortality
D007075:Immunoglobulin M; D053594:Myeloid Differentiation Factor 88
Diagnosis; IgM monoclonal gammopathy; MYD88 mutation; Prognosis; Waldenström macroglobulinaemia